from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3032/-

LFCtreatmentdescriptionclass of inhibitor

-0.834

Amikacinug/mL Amikacintranslation

0.464

Cap5-10ug/mL Capreomycintranslation

-0.956

Rox10-50 ug/mL Roxithromycintranslation

0.042

SM2-5 ug/mL Streptomycintranslation

-1.548

Tet5-10 ug/mL Tetracyclinetranslation

0.265

Rif0.2-5ug/mL Rifampicintranscription

0.751

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.479

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.473

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.927

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.750

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.258

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.347

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.207

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.729

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.089

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.217

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.281

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.601

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.808

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.580

KCN5-20 ug/mL Potassium cyaniderespiration

0.067

NaN30.2-2 mM Sodium aziderespiration

0.482

Nigericin50 uM Nigericinrespiration

0.000

TRC10-150 ug/mL Triclosanrespiration

-0.444

TRZ10-25 ug/mL Thioridazinerespiration

-0.815

Valinomycin0.5-10 uM Valinomycinrespiration

-0.234

ZnSO42 mM ZnSO4respiration

1.716

menadione6-10 ug/mL Menadionerespiration

-0.037

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.351

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.588

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.040

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.387

NRP_1Non-replicating persistence stage 1dosRassociated

-1.269

Amp0.2mg/mL AmpicillincellWall

0.488

Cephalexin20-100 ug/mL CephalexincellWall

0.436

Cerulenin0.32-5 ug/mL CerulenincellWall

0.211

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.100

EMB10-20 ug/mL EthambutolcellWall

0.521

Eta12-40 ug/mL EthionamidecellWall

1.058

INH0.2-0.4 ug/mL IsoniazidcellWall

0.227

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.250

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.618

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.524

BZA0.12 mg/mL BenzamidearomaticAmides

0.380

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.195

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.563

H2O24 mM hydrogen peroxideDNAdamaging

0.310

Levo10 ug/mL LevofloxacinDNAdamaging

0.691

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.001

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.506

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.110

UVUV-irradiationDNAdamaging

1.593

ARP41-4 ug/mL Antitubercular compound ARP4?

0.089

Antimycin12.5-50 ug/mL Antimycin A?

-0.312

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.319

PA_110-50 ug/mL Antitubercular compound PA-1?

0.061

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.145

PA8240.2-2 ug/mL PA-824?

-0.097

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.275

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.351

Verapamil50 uM Verapamil?

-0.014

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.366

methoxatin10-20 ug/mL Methoxatin?